Group 1 - The company, Jiahe Intelligent, announced the use of temporarily idle raised funds amounting to 500 million yuan to purchase structured deposits [2] - The structured deposits include 200 million yuan in a currency-linked structured deposit from CITIC Bank and 300 million yuan in a unit structured deposit from Dongguan Bank, both maturing on March 9, 2026 [2] - As of the date of the announcement, the remaining balance of these investments is 500 million yuan [2]

佳禾智能科技股份有限公司（以下简称"公司"）于 2024 年 12 月 24 日召 开第三届董事会第二十一次会议、第三届监事会第十五次会议，审议通过了《关 于使用闲置募集资金进行现金管理的议案》，同意公司（含全资子公司）在确 保不影响正常运营和募集资金投资项目建设的情况下，使用不超 5 亿元（含本 数）闲置募集资金进行现金管理，上述额度有效期为自 2025 年 1 月 30 日起至 2025 年 12 月 31 日止，在前述额度和期限范围内，可循环滚动使用。闲置募集 资金现金管理到期后将及时归还至募集资金专户。同时授权公司董事长在上述 额度内签署相关合同文件，公司财务部负责组织实施。上述内容详见 2024 年 12 月 24 日公司刊登在巨潮资讯网（www.cninfo.com.cn）《关于使用自有资金及 闲置募集资金进行现金管理的公告》（公告编号：2024-120）。 公司于 2025 年 12 月 24 日召开第三届董事会第三十二次会议审议通过了 《关于使用闲置募集资金进行现金管理的议案》，同意公司（含全资子公司） 在确保不影响正常运营和募集资金投资项目的情况下，使用不超过 7 亿元（含 本数）闲置募集资 ...

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 佳禾智能科技股份有限公司（以下简称"公司"）于2024年12月24日召开 第三届董事会第二十一次会议、第三届监事会第十五次会议，审议通过了《关 于使用自有资金进行现金管理的议案》，同意公司（含全资子公司）在确保不影 响正常运营情况下，使用不超过7.5亿元（含本数）自有资金进行现金管理，投 资由商业银行等金融机构发行的安全性高、流动性好、短期（不超过12个月）的 投资理财品种，上述额度有效期为自2025年1月30日起至2025年12月31日止，在 前述额度和期限范围内，可循环滚动使用。上述内容详见2024年12月24日公司刊 登在巨潮资讯网（www.cninfo.com.cn）《关于使用自有资金及闲置募集资金进 行现金管理的公告》（公告编号：2024-120）。 公司于2025年12月24日召开第三届董事会第三十二次会议审议通过了《关 于使用自有资金进行现金管理的议案》，同意公司（含全资子公司）在确保不影 响正常运营情况下，使用不超过7亿元（含本数）自有资金进行现金管理，投资 由商业银行等金融机构发行的安全性高、流 ...

Group 1 - The blood oxygen monitor concept sector rose by 5.65%, ranking third among concept sectors, with 24 stocks increasing, including Aipeng Medical and Lepu Medical reaching a 20% limit up [1] - The top gainers in the blood oxygen monitor sector included Jiahe Intelligent, Kefu Medical, and Libang Instruments, which rose by 13.18%, 11.10%, and 7.82% respectively [1] - The blood oxygen monitor sector saw a net inflow of 943 million yuan from main funds, with 15 stocks receiving net inflows, and 7 stocks exceeding 10 million yuan in net inflow [1] Group 2 - The leading stocks in terms of net inflow ratio included Aipeng Medical, Lepu Medical, and Hongri Pharmaceutical, with net inflow ratios of 25.43%, 18.55%, and 14.65% respectively [2] - The top stocks by main fund flow in the blood oxygen monitor sector included Lepu Medical with a net inflow of 485 million yuan, followed by Sichuan Changhong and Aipeng Medical with net inflows of 195 million yuan and 156 million yuan respectively [2] - The trading performance of various stocks showed significant fluctuations, with some stocks like Aipeng Medical and Lepu Medical achieving notable gains and high turnover rates [3]

Core Insights - The consumer electronics sector experienced a significant increase of 2.82% on January 5, with Jiahe Intelligent leading the gains [1] - The Shanghai Composite Index closed at 4023.42, up 1.38%, while the Shenzhen Component Index closed at 13828.63, up 2.24% [1] Stock Performance - Jiahe Intelligent (300793) closed at 18.46, with a rise of 13.18% and a trading volume of 550,800 shares, amounting to a transaction value of 979 million [1] - Darui Electronics (300976) saw a closing price of 67.70, increasing by 12.70% with a trading volume of 86,800 shares, resulting in a transaction value of 569 million [1] - Xiechuang Data (300857) closed at 185.73, up 10.11%, with a trading volume of 282,600 shares and a transaction value of 5.108 billion [1] - Other notable performers included Kechuan Technology (603052) at 34.71 (+10.02%), Longqi Technology (603341) at 46.49 (+10.01%), and Yingqu Technology (002925) at 18.63 (+9.98%) [1] Capital Flow - The consumer electronics sector saw a net outflow of 1.085 billion from institutional investors, while retail investors contributed a net inflow of 1.845 billion [2] - Notable stocks with significant capital flow included Yingqu Technology (002925) with a net inflow of 153 million from institutional investors, despite a net outflow of 84.96 million from speculative funds [3] - Longqi Technology (603341) had a net inflow of 120 million from institutional investors, while experiencing a net outflow of 126 million from speculative funds [3]

1、佳禾转债（债券代码：123237）转股期为2024年7月10日至2030年1月3日； 最新转股价为13.46元/股。 2、2025年第四季度：共有950张佳禾转债完成转股（票面金额共计95,000元）， 合计转成7,054股佳禾智能 A 股股票（股票代码：300793）。 3、截至2025年12月31日，公司剩余可转债为4,314,674张，剩余票面总金额 为431,467,400元。 | 证券代码：300793 | 证券简称：佳禾智能 | 公告编号：2026-001 | | --- | --- | --- | | 债券代码：123237 | 债券简称：佳禾转债 | | 佳禾智能科技股份有限公司 关于 2025 年第四季度可转债转股情况的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在任何虚假记 载、误导性陈述或者重大遗漏。 根据《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自 律监管指引第15号——可转换公司债券》的有关规定，佳禾智能科技股份有限公 司（以下简称"公司"）现将2025年第四季度可转换公司债券（以下简称"佳禾 转债"）转股及公司总股本变化情况公告如下： 特别提 ...

Group 1 - The Shanghai Composite Index is at 4005.73 points, above the annual line, with an increase of 0.93% [1] - The total trading volume of A-shares today is 1,402.986 billion yuan [1] - A total of 154 A-shares have surpassed the annual line, with notable stocks showing significant deviation rates including Yingkang Life, Gangtong Medical, and Beilu Pharmaceutical at 10.63%, 10.61%, and 9.97% respectively [1] Group 2 - The top three stocks with the highest deviation rates from the annual line are: - Yingkang Life (12.85% increase, 10.63% deviation) - Gangtong Medical (11.91% increase, 10.61% deviation) - Beilu Pharmaceutical (10.20% increase, 9.97% deviation) [1] - Other notable stocks with significant increases include: - Guanhao Biological (14.87% increase, 8.29% deviation) - Baichu Electronics (6.95% increase, 6.79% deviation) [1] - Stocks with smaller deviation rates that have just crossed the annual line include *ST Yedao, Shiyan Institute, and Shanxi Securities [1]

| 证券代码：300793 | 证券简称：佳禾智能 | 公告编号：2025-112 | | --- | --- | --- | | 债券代码：123237 | 债券简称：佳禾转债 | | 佳禾智能科技股份有限公司 关于控股股东股份减持计划实施完毕的公告 东莞市文富实业投资有限公司保证向本公司提供的信息内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 佳禾智能科技股份有限公司（以下简称"公司"）于 2025 年 9 月 8 日披露 了《关于控股股东减持计划预披露的公告》（公告编号：2025-087）。持公司股 份 105,600,000 股（占公司剔除回购专用证券账户持股数量的总股本的比例 28.04%）的控股股东东莞市文富实业投资有限公司(以下简称"文富投资")，计 划自本公告披露之日起 15 个交易日后的 3 个月内（即 2025 年 9 月 30 日至 2025 年 12 月 29 日）拟减持公司股份合计不超过 6,000,000 股（占公司剔除回购专用 证券账户持股数量的总股本的比例 1.59%）。其中，通过集中竞价交易方式 ...

| 证券代码：300793 | 证券简称：佳禾智能 | 公告编号：2025-111 | | --- | --- | --- | | 债券代码：123237 | 债券简称：佳禾转债 | | 佳禾智能科技股份有限公司 关于收购事项获得发改委、商务部门备案的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在任何虚假记 载、误导性陈述或者重大遗漏。 一、本次交易概述 佳禾智能科技股份有限公司（以下简称"公司"）全资子公司 Cosonic International Pte. Ltd（以下简称"佳禾国际"）拟收购 Carol Shirley Beyer、 Carina-Gloria Mühling、Kaja Mühling、Daniela Gruidl、Dennis Gruidl、Samantha Carina Edwards、David Edwards（以下合称"卖方"或"交易对方"）持有的 beyerdynamic GmbH & Co. KG（以下简称"标的公司"或"BD KG"，系一家注 册于德国的有限合伙企业）的全部有限合伙权益，卖方持有的 BD KG 的普通合 伙人 BEYER DYNAMI ...

Core Viewpoint - Jiahe Intelligent Technology Co., Ltd. is actively engaging in financial management and strategic acquisitions to enhance its operational efficiency and mitigate risks associated with currency fluctuations and cash flow management [1][4]. Group 1: Financial Management Initiatives - The company plans to use up to 800 million RMB or equivalent foreign currency for foreign exchange hedging to mitigate currency risk from exports [3][5]. - Jiahe Intelligent intends to conduct accounts receivable factoring business with a total amount not exceeding 800 million RMB, aimed at optimizing cash flow management [3][4]. - The company will utilize up to 700 million RMB of its own funds and 700 million RMB of idle raised funds for cash management, focusing on high-security, liquid short-term financial products [6][5]. Group 2: Acquisition Plans - Jiahe Intelligent's wholly-owned subsidiary, Cosonic International Pte. Ltd., plans to acquire all limited partnership interests and related shares of beyerdynamic GmbH & Co. KG, with a waiver agreement signed to extend the transaction deadline to April 30, 2026 [2][4]. - The acquisition agreement includes provisions for mutual waiver of rights related to regulatory approvals, allowing for negotiations on extending the waiver period if necessary [2][4]. Group 3: Upcoming Corporate Actions - The company will hold its first extraordinary general meeting of 2026 on January 9, 2026, to discuss the waiver agreement related to the acquisition, requiring a majority vote from shareholders [7]. - The interest payment for the "Jiahe Convertible Bonds" will be made on January 5, 2026, with a coupon rate of 0.40% for the period from January 4, 2025, to January 3, 2026 [8].